Yamada K, Goto S, Hamasaki T, Kuratsu J-I
Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Acta Neurochir (Wien). 2008 Jan;150(1):15-22; discussion 22. doi: 10.1007/s00701-007-1451-3. Epub 2008 Jan 10.
The levodopa responsiveness of motor, particularly axial symptoms is a good predictor of the effectiveness of subthalamic nucleus (STN) stimulation in patients with Parkinson's disease (PD). However, many Japanese PD patients are intolerant of higher doses of antiparkinsonian drugs and some aspects of their axial symptoms may remain unresponsive to treatment. We retrospectively investigated the effects of bilateral STN stimulation on the axial signs unresponsive to levodopa in Japanese patients with PD.
We enrolled 29 consecutive patients into this study. Six independent axial symptoms, i.e. falling, freezing, gait, standing, posture, and postural instability, were scored on the Unified Parkinson's Disease Rating Scale (UPDRS), before and 3 months after bilateral STN stimulation and differences were statistically analysed.
Postoperatively, the mean levodopa dosage was decreased by 27%. The preoperative responsiveness to antiparkinsonian drugs with respect to freezing, gait, posture, and postural instability were positively correlated with postoperative off-medication improvement (p < 0.05). For each individual axial symptom, some patients showed an excellent response to STN stimulation, despite preoperative unresponsiveness to levodopa. These selected patients were not always treated with lower doses of antiparkinsonian drugs preoperatively, but they had milder preoperative scores on the UPDRS with respect to daily activities and overall axial function.
The axial symptoms of PD unresponsive to levodopa were ameliorated by bilateral STN stimulation in patients manifesting a milder degree of preoperative axial signs. Our findings suggest that STN stimulation exerted a definite but limited effect on levodopa-unresponsive axial features, pointing to the need to identify different target structures that control axial functions via non-dopaminergic systems.
运动症状尤其是轴性症状对左旋多巴的反应性是帕金森病(PD)患者丘脑底核(STN)刺激疗效的良好预测指标。然而,许多日本PD患者不耐受高剂量的抗帕金森病药物,且其某些轴性症状可能对治疗无反应。我们回顾性研究了双侧STN刺激对日本PD患者中对左旋多巴无反应的轴性体征的影响。
我们连续纳入29例患者进行本研究。在双侧STN刺激前及刺激后3个月,使用统一帕金森病评定量表(UPDRS)对六个独立的轴性症状,即跌倒、冻结、步态、站立、姿势和姿势不稳进行评分,并对差异进行统计学分析。
术后,左旋多巴的平均剂量降低了27%。术前抗帕金森病药物对冻结、步态、姿势和姿势不稳的反应性与术后停药时的改善情况呈正相关(p<0.05)。对于每个单独的轴性症状,一些患者尽管术前对左旋多巴无反应,但对STN刺激表现出良好反应。这些选定的患者术前并非总是接受较低剂量的抗帕金森病药物治疗,但他们在UPDRS的日常活动和整体轴性功能方面术前评分较低。
在术前轴性体征程度较轻的患者中,双侧STN刺激改善了对左旋多巴无反应的PD轴性症状。我们的研究结果表明,STN刺激对左旋多巴无反应的轴性特征有一定但有限的作用,这表明需要识别通过非多巴胺能系统控制轴性功能的不同靶结构。